Halozyme Therapeutics: Q3 Earnings Snapshot

Barchart · 1d ago

SAN DIEGO (AP) — SAN DIEGO (AP) — Halozyme Therapeutics Inc. (HALO) on Thursday reported third-quarter net income of $247 million.

On a per-share basis, the San Diego-based company said it had net income of $2.01. Earnings, adjusted for one-time gains and costs, were $2.39 per share.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of $2.29 per share.

The biopharmaceutical company posted revenue of $493 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $482 million.

Halozyme Therapeutics expects full-year earnings in the range of $8.75 to $9.05 per share, with revenue in the range of $1.86 billion to $1.93 billion.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HALO at https://www.zacks.com/ap/HALO